Literature DB >> 9163586

Beta-thalassaemia in the immigrant and non-immigrant German populations.

B Vetter1, C Schwarz, E Kohne, A E Kulozik.   

Abstract

In Germany homozygous beta-thalassaemia mainly occurs in the immigrant population from endemic regions. In non-immigrants beta-thalassaemia is rare. Heterozygous beta-thalassaemia minor, however, is more common and must be considered in the differential diagnosis of hypochromic anaemia. The clinical and molecular data of 221 homozygous patients and 256 non-immigrant German heterozygous individuals are presented. Clinically, 87% (n = 192) of the homozygotes are classified as thalassaemia major (TM) and the other 13% as thalassaemia intermedia (TI). There is a wide spectrum of 39 thalassaemia mutations which occur with relatively low frequencies in individual cases. In 17/29 TI patients 'mild' mutations have been found and in 16/29 there are mutations that are associated with increased gamma-globin gene activity. alpha-Thalassaemia is rare and found only in 3/29. In the 256 Germans with heterozygous beta-thalassaemia there are 27 different thalassaemia mutations. The three most common are Mediterranean, together accounting for 61%. Also relatively common (5%) is an otherwise rare frameshift mutation of codon 83 (FS83 deltaG). The other mutations occur in < 10 individuals. Two mutations described here are novel. One of them affects position -2 of the intron 1 splice acceptor site (IVSI-129 A-G) and the other is a deletion of a single G in codon 15/16 (FS 15/16 deltaG). These data suggest that beta-thalassaemia in Germans was introduced from the Mediterranean in about two-thirds of cases and that the remaining third has probably originated locally.

Entities:  

Mesh:

Year:  1997        PMID: 9163586     DOI: 10.1046/j.1365-2141.1997.342674.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Binary specification of nonsense codons by splicing and cytoplasmic translation.

Authors:  R Thermann; G Neu-Yilik; A Deters; U Frede; K Wehr; C Hagemeier; M W Hentze; A E Kulozik
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

2.  Hemoglobinopathies: a longitudinal study over four decades.

Authors:  Elisabeth Kohne; Enno Kleihauer
Journal:  Dtsch Arztebl Int       Date:  2010-02-05       Impact factor: 5.594

3.  Hb S/β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.

Authors:  André R Belisário; Anna B Carneiro-Proietti; Ester Cerdeira Sabino; Aderson Araújo; Paula Loureiro; Cláudia Máximo; Miriam V Flor-Park; Daniela D O W Rodrigues; Mina Cintho Ozahata; Christopher McClure; Rosimere Afonso Mota; Isabel C Gomes Moura; Brian Custer; Shannon Kelly
Journal:  Hemoglobin       Date:  2020-03-16       Impact factor: 0.849

4.  Application of diagnostic methods and molecular diagnosis of hemoglobin disorders in Khuzestan province of Iran.

Authors:  Rahim Fakher; Kaeikhaei Bijan; Akbari Mohammad Taghi
Journal:  Indian J Hum Genet       Date:  2007-01

5.  Confirmation of a founder effect in a Northern European population of a new β-globin variant: HBB:c.23_26dup (codons 8/9 (+AGAA)).

Authors:  Nina Marchi; Serge Pissard; Manuel Cliquennois; Christian Vasseur; Nathalie Le Metayer; Claude Mereau; Jean Pierre Jouet; Anne-France Georgel; Emmanuelle Genin; Christian Rose
Journal:  Eur J Hum Genet       Date:  2014-12-03       Impact factor: 4.246

6.  Mutation Spectrum of the ABCA4 Gene in a Greek Cohort with Stargardt Disease: Identification of Novel Mutations and Evidence of Three Prevalent Mutated Alleles.

Authors:  Kamakari Smaragda; Kokkinou Vassiliki; Koutsodontis George; Stamatiou Polixeni; Giatzakis Christoforos; Anastasakis Anastasios; Aslanides Ioannis Minas; Koukoula Stavrenia; Panagiotoglou Theoni; Datseris Ioannis; Tsilimbaris K Miltiadis
Journal:  J Ophthalmol       Date:  2018-04-30       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.